Quantics is a biostatistical solutions provider for the bioscience and medical devices industries. Through our expert consultancy and QuBAS, our powerful bioassay software, we deliver rapid, guaranteed reliable results that make the most of every datapoint, helping clients to move rapidly through research and development to market approval.
We specialise in biostatistical services and tools to improve outcomes from lab to licence
Quantics is owned by the employees of the company. This means that everyone working at Quantics has a vested interest in ensuring the success of our clients.
The company is and will remain independent so our clients can be confident that they will always receive a personalised service.
“We love stats, so you don’t have to.”
Quantics provides an independent QA certificate for all GLP and GMP work to satisfy all the regulatory requirements.
Clients are welcome to conduct an on-site or remote audit should they wish.
Quantics is delighted to confirm that we have once again passed our latest ISO9001 audit.
You can view our up-to-date ISO certificate here:
Quantics has a diverse mix of highly qualified and experienced statistical, scientific and medical staff. This ensures that not only do we understand the scientific or medical questions being asked, design the appropriate experiments and trials, and analyse the data using the optimal statistical techniques, but we can also interpret and communicate the results back to the client.
Christophe joined Quantics in 2015. He has a PhD in Pattern Recognition from the University of London, a Masters in Artificial Intelligence from the Université Pierre et Marie Curie and a degree in mathematics from Université Paris. Christophe leads our team of programmers for both our consultancy clients and our proprietary QuBAS Bioassay Software.
Sandra joined Quantics in 2017. She has a PhD and Masters both in Mathematics from the University of Bonn in Germany. Since joining Quantics, Sandra has been a key member of our Clinical, Bioassay and HTA teams and is the responsible statistician for many of our key client clinical trials for medical devices and pharmaceuticals.
Graduating in Marketing and Business Philip held several senior commercial roles in ICI, AstraZeneca, Avecia, PharmAthene, working with Quantics since 2015. He has operated internationally in vaccines, pharmaceuticals, biosciences, specialty chemicals and has previously been a client of Quantics as Programme Director for a US, UK and Canadian Government funded Recombinant Plague Vaccine Programme.
Founder of Quantics Biostatistics & USP Expert Committee Member (Statistics) spent her entire professional life helping clients with statistical issues. From 1991-93 she was Head of the Mathematics and Statistics section of Shell Research, then joined the Information and Statistics Division of NHS Scotland (ISD). Starting as Head and Principal Statistician of the Scottish Cancer Therapy Network within ISD, she rose to become Assistant Director of ISD before establishing Quantics in 2002. Ann has a degree in mathematics and Masters in statistics from Oxford University, and a PhD in Statistics from Waterloo (Canada),
Ian Yellowlees has an engineering degree and experience in software engineering and is also fully medically qualified, with 20+ years experience as an NHS consultant. He developed Quantics’ unique ISO9001 and GXP quality management system and provides business management and medical support to Quantics.
Matthew has been working with Quantics Biostatistics since 2015. He completed his PhD in Statistics at the University of Guelph in 2019, and was awarded the 2020 Canadian Journal of Statistics Award for his research on leveraging the graphical structure among predictors to improve outcome prediction. Following a stint as Assistant Professor in Statistics at the University of New Brunswick from 2020-2022, he resumed a full-time role at Quantics in 2023.
